Biotech12 hours ago
New Advances in HIV PrEP: An Annual Injection of Lenacapavir May Be Sufficient
A new study in The Lancet shows annual lenacapavir injections could revolutionize HIV prevention, with up to 100% risk reduction in trials. While effective, challenges include...